Pyramid Biosciences Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $50M

Pyramid Biosciences General Information

Description

Operator of an oncology company intended to treat disorders that the tropomyosin receptor kinase family regulates. The company's therapeutics include precisely and selectively modulating the actions of fundamental cell surface receptors and controlling the key signaling pathways responsible for a patient's disease, condition, or symptoms, enabling physicians to regulate the symptoms and alter the progression of diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 330 Bear Hill Road
  • Suite 302
  • Waltham, MA 02451
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 330 Bear Hill Road
  • Suite 302
  • Waltham, MA 02451
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pyramid Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 07-Jan-2024 $50M Completed Clinical Trials - Phase 1
6. Later Stage VC (Series B) 15-Oct-2021 Completed Clinical Trials - Phase 1
5. Later Stage VC (Series A3) 31-Aug-2020 Completed Clinical Trials - Phase 1
4. Later Stage VC (Series A2) 28-Jul-2020 Completed Clinical Trials - Phase 1
3. Later Stage VC (Series A) 28-Jul-2020 Completed Clinical Trials - Phase 1
2. Early Stage VC 31-Jul-2018 $17.3K $17.3K Completed Clinical Trials - Phase 1
1. Angel (individual) 01-Jan-2016 Completed Clinical Trials - Phase 1
To view Pyramid Biosciences’s complete valuation and funding history, request access »

Pyramid Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A4
Series A3
Series A2 1,500,000 $0.000100 8% $4 $4 1x $4 11.59%
Series A 1,054,586 $0.000100 8% $3.44 $3.44 1x $3.44 8.15%
To view Pyramid Biosciences’s complete cap table history, request access »

Pyramid Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of an oncology company intended to treat disorders that the tropomyosin receptor kinase family regulates. The c
Drug Discovery
Waltham, MA
11 As of 2023

Lexington, MA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pyramid Biosciences Competitors (78)

One of Pyramid Biosciences’s 78 competitors is Accent Therapeutics, a Venture Capital-Backed company based in Lexington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Accent Therapeutics Venture Capital-Backed Lexington, MA
AsherBio Venture Capital-Backed South San Francisco, CA
Linnaeus Therapeutics Venture Capital-Backed Haddonfield, NJ
Complix Venture Capital-Backed Diepenbeek, Belgium
Actym Therapeutics Venture Capital-Backed Berkeley, CA
You’re viewing 5 of 78 competitors. Get the full list »

Pyramid Biosciences Patents

Pyramid Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023248151-A1 Method of treating skin field cancerization with actinic keratoses Inactive 24-Jun-2022
AU-2021415273-A1 Topical pharmaceutical compositions and methods Inactive 29-Dec-2020
AU-2021415273-A9 Topical pharmaceutical compositions and methods Inactive 29-Dec-2020
CA-3204701-A1 Topical pharmaceutical compositions and methods Pending 29-Dec-2020
US-20240092778-A1 Topical pharmaceutical compositions and methods Pending 29-Dec-2020 C07D471/04
To view Pyramid Biosciences’s complete patent history, request access »

Pyramid Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pyramid Biosciences Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Adage Capital Management Hedge Fund Minority
Alpine Meridian Venture Capital Minority
Boston Harbor Angels Angel Group Minority
Montanova Capital Hedge Fund Minority
Oracle Investment Management Hedge Fund Minority
You’re viewing 5 of 6 investors. Get the full list »

Pyramid Biosciences FAQs

  • When was Pyramid Biosciences founded?

    Pyramid Biosciences was founded in 2015.

  • Where is Pyramid Biosciences headquartered?

    Pyramid Biosciences is headquartered in Waltham, MA.

  • What is the size of Pyramid Biosciences?

    Pyramid Biosciences has 11 total employees.

  • What industry is Pyramid Biosciences in?

    Pyramid Biosciences’s primary industry is Drug Discovery.

  • Is Pyramid Biosciences a private or public company?

    Pyramid Biosciences is a Private company.

  • What is the current valuation of Pyramid Biosciences?

    The current valuation of Pyramid Biosciences is .

  • What is Pyramid Biosciences’s current revenue?

    The current revenue for Pyramid Biosciences is .

  • How much funding has Pyramid Biosciences raised over time?

    Pyramid Biosciences has raised $71.2M.

  • Who are Pyramid Biosciences’s investors?

    Adage Capital Management, Alpine Meridian, Boston Harbor Angels, Montanova Capital, and Oracle Investment Management are 5 of 6 investors who have invested in Pyramid Biosciences.

  • Who are Pyramid Biosciences’s competitors?

    Accent Therapeutics, AsherBio, Linnaeus Therapeutics, Complix, and Actym Therapeutics are some of the 78 competitors of Pyramid Biosciences.

  • When was Pyramid Biosciences acquired?

    Pyramid Biosciences was acquired on 07-Jan-2024.

  • Who acquired Pyramid Biosciences?

    Pyramid Biosciences was acquired by Biohaven.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process